STABILISE SELECTIVE TREATMENT OF ATHEROSCLEROSIS: DARAPLADIB INIHIBITS LP-PLA2 WITH ANTI-INFLAMMATORY AND PLAQUE STABILISING EFFECTS Trademark

Trademark Overview


On Monday, October 22, 2007, a trademark application was filed for STABILISE SELECTIVE TREATMENT OF ATHEROSCLEROSIS: DARAPLADIB INIHIBITS LP-PLA2 WITH ANTI-INFLAMMATORY AND PLAQUE STABILISING EFFECTS with the United States Patent and Trademark Office. The USPTO has given the STABILISE SELECTIVE TREATMENT OF ATHEROSCLEROSIS: DARAPLADIB INIHIBITS LP-PLA2 WITH ANTI-INFLAMMATORY AND PLAQUE STABILISING EFFECTS trademark a serial number of 77309541. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 2, 2010. This trademark is owned by Glaxo Group Limited. The STABILISE SELECTIVE TREATMENT OF ATHEROSCLEROSIS: DARAPLADIB INIHIBITS LP-PLA2 WITH ANTI-INFLAMMATORY AND PLAQUE STABILISING EFFECTS trademark is filed in the Paper & Printed Material Products and Computer & Software Services & Scientific Services categories with the following description:

Printed materials, namely, pamphlets and brochures featuring the treatment and prevention of cardiovascular diseases and disorders

Medical and scientific research, namely, conducting clinical trials for pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders
stabilise selective treatment of atherosclerosis: darapladib inihibits lp-pla2 with anti-inflammatory and plaque stabilising effects

General Information


Serial Number77309541
Word MarkSTABILISE SELECTIVE TREATMENT OF ATHEROSCLEROSIS: DARAPLADIB INIHIBITS LP-PLA2 WITH ANTI-INFLAMMATORY AND PLAQUE STABILISING EFFECTS
Filing DateMonday, October 22, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 2, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 7, 2008

Trademark Statements


Disclaimer with Predetermined Text"SELECTIVE TREATMENT OF ATHEROSCLEROSIS:DARAPLADIB INIHIBITS LP-PLA2 WITH ANTI-INFLAMMATORY AND PLAQUE STABILISING EFFECTS"
Goods and ServicesPrinted materials, namely, pamphlets and brochures featuring the treatment and prevention of cardiovascular diseases and disorders
Goods and ServicesMedical and scientific research, namely, conducting clinical trials for pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders
Pseudo MarkSTABILISE SELECTIVE TREATMENT OF ATHEROSCLEROSIS: DARAPLADIB INIHIBITS LP-PLA TWO WITH ANTI-INFLAMMATORY AND PLAQUE STABILISING EFFECTS

Classification Information


International Class016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks.
US Class Codes002, 005, 022, 023, 029, 037, 038, 050
Class Status Code6 - Active
Class Status DateThursday, October 25, 2007
Primary Code016
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 25, 2007
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN

Trademark Events


Event DateEvent Description
Monday, August 2, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 2, 2010ABANDONMENT - NO USE STATEMENT FILED
Wednesday, May 12, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 3, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, January 30, 2010EXTENSION 2 GRANTED
Monday, December 21, 2009EXTENSION 2 FILED
Friday, January 29, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 21, 2009TEAS EXTENSION RECEIVED
Thursday, October 29, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 22, 2009EXTENSION 1 GRANTED
Monday, June 29, 2009EXTENSION 1 FILED
Wednesday, July 22, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 29, 2009TEAS EXTENSION RECEIVED
Tuesday, June 2, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 2, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 30, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 7, 2008PUBLISHED FOR OPPOSITION
Wednesday, September 17, 2008NOTICE OF PUBLICATION
Thursday, September 4, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, September 4, 2008ASSIGNED TO LIE
Tuesday, August 26, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 26, 2008EXAMINER'S AMENDMENT ENTERED
Tuesday, August 26, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 26, 2008EXAMINERS AMENDMENT E-MAILED
Tuesday, August 26, 2008EXAMINERS AMENDMENT -WRITTEN
Thursday, June 26, 2008NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, June 26, 2008FINAL REFUSAL E-MAILED
Thursday, June 26, 2008FINAL REFUSAL WRITTEN
Friday, June 6, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 6, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 6, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 7, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 7, 2007NON-FINAL ACTION E-MAILED
Friday, December 7, 2007NON-FINAL ACTION WRITTEN
Monday, December 3, 2007ASSIGNED TO EXAMINER
Friday, October 26, 2007NOTICE OF PSEUDO MARK MAILED
Thursday, October 25, 2007NEW APPLICATION ENTERED IN TRAM